Development
Hydreight Technologies Inc.
NURS.V
TSX
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 14.57% | 3.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.57% | 3.28% | |||
| Cost of Revenue | 12.47% | 19.99% | |||
| Gross Profit | 17.73% | -14.57% | |||
| SG&A Expenses | 13.53% | 39.96% | |||
| Depreciation & Amortization | -53.72% | 2.54% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.64% | 28.67% | |||
| Operating Income | -0.71% | -350.15% | |||
| Income Before Tax | 0.88% | -540.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.88% | -540.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.88% | -540.78% | |||
| EBIT | -0.71% | -350.15% | |||
| EBITDA | -0.59% | -337.15% | |||
| EPS Basic | 2.15% | -542.86% | |||
| Normalized Basic EPS | 1.72% | -546.15% | |||
| EPS Diluted | 2.15% | -542.86% | |||
| Normalized Diluted EPS | 1.72% | -546.15% | |||
| Average Basic Shares Outstanding | 1.01% | 0.00% | |||
| Average Diluted Shares Outstanding | 1.01% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||